News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Sorin Group S.p.A. Settles Legal Action Against ATS Medical, Inc.
December 29, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MILAN, Italy--(BUSINESS WIRE)--Sorin Group (MIL:SRN), (Reuters Code: SORN.MI), a global company and a leader in the treatment of cardiovascular diseases, announced today the settlement of a lawsuit related to its supply agreement with ATS Medical.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Europe
MORE ON THIS TOPIC
Insights
The Italian inflection point: Clinical strength, culture and capital
August 13, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Legal
Lilly cracks down on black market for obesity asset retatrutide with six lawsuits
August 12, 2026
·
2 min read
·
Tristan Manalac
Insights
Austria’s new growth fund could further bolster its dynamic biotech innovation economy
August 11, 2026
·
5 min read
·
Jennifer C. Smith-Parker
Regulatory
Lilly, FDA retatrutide biologic dispute comes to a head as submission nears
August 5, 2026
·
3 min read
·
Annalee Armstrong